Sodium Fluoride PET/CT in Clinical Use

Prof. Kairemo graduated with an MSc (Eng) degree from Helsinki University of Technology in 1980 before undertaking medical training (MD, PhD) at the University of Helsinki, Finland. He subsequently completed specialist training in Clinical Chemistry, Nuclear Medicine and Clinical Pharmacology at Helsinki University Central Hospital (HUCH), followed by a research fellowship at Memorial Sloan-Kettering Cancer Center in New York (1989-93). He has held posts as Professor of Clinical Chemistry at the Norwegian University of Science and Technology (1998-99), Professor of Nuclear Medicine at Uppsala University Hospital in Sweden (2001-05) and as Head of the Nuclear Medicine Division, Department of Oncology at HUCH (2004-09). From 2009 to 2018, he was Chief of Nuclear Medicine and Molecular Radiotherapy at the Docrates Cancer Center in Helsinki. Since 2015 he has also been a Visiting Professor (Nuclear Medicine) at the University of Texas MD Anderson Cancer Center. Besides holding a few patents he has published more than 200 original articles in peer-reviewed journals. In 2012, he received the Lifetime Achievement Award from the World Association of Radiopharmaceutical and Molecular Therapy.

18F-Fluoride Imaging: Tracer and Technique.- 18F-Fluoride Imaging: Normal variants and artefacts.- Sodium fluoride imaging in oncology.- 18F-Fluoride Imaging: Monitoring therapy.- Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.- 18F-Fluoride: Benign Bone Disease.- Dynamic 18F-Fluoride Imaging.- 18F-Fluoride Imaging: Atlas of interesting images (images with specific teaching points, tracer, technique and pitfalls).- Role of Sodium Fluoride-PET in Primary Bone Tumors.- 18F-Sodium Fluoride Positron Emission Tomography in Cardiac Disease.- 18F-Sodium Fluoride positron emission tomography / computed tomography imaging of the peripheral vasculature.